Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Neurogenic Bowel: early-phase trial registry

1 of 5 indexed Neurogenic Bowel trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Neurogenic Bowel: 5 US clinical trials tracked, 1 recruiting.

Neurogenic Bowel is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is James J. Peters Veterans Affairs Medical Center, running 3 of these trials.

Enrollment posture brief

Registry condition neurogenic-bowel

OPEN 1 | RECR 20% | LATE 1 | EARLY 2 | RANK #3391 | SPON 3

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Neurogenic Bowel (this)20%
Open-enrollment share among volume-matched conditions near Neurogenic Bowel

Neurogenic Bowel lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Neurogenic Bowel on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Neurogenic Bowel is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Neurogenic Bowel research.

    James J. Peters Veterans Affairs Medical Center accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Neurogenic Bowel trials plan to enrol fewer than 100 people.

    Median target enrolment is 6 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.

  4. Neurogenic Bowel research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 31

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 1

Top Sponsors

James J. Peters Veterans Affairs Medical Center 3 trials
Craig Hospital 1 trials
University of Michigan 1 trials

Named interventions

Most-linked intervention names on Neurogenic Bowel records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

I-Box by Dynatronics Device
2 trials
Combination of Neostigmine and Glycopyrrolate Drug
2 trials
Iontophoresis Device
1 trials
Neostigmine and Glycopyrrolate Drug
1 trials
Health Mechanics Program Behavioral
1 trials
Abdominal Functional Electrical Stimulation Behavioral
1 trials

US sites by state

Facility locations filed on Neurogenic Bowel trials. A trial with sites in several states counts in each.

New York 3 trials
Michigan 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Neurogenic Bowel page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurogenic Bowel condition card totals 5 registered trials; most-linked intervention I-Box by Dynatronics; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.